Pfizer Posts $4.9B 1Q Profit as Vaccine Strategy Pays Off


Pfizer's vaccine strategy boosted its bottom line for the first three months of the year Pfizer says it earned four point nine billion dollars the company is doubling its sales projections for the coronavirus vaccine this year from fifteen billion dollars to roughly twenty six billion the Pfizer vaccine developed along with partner by on tech has proven to be more than ninety percent effective and is rapidly one emergency approval in country after country the partners are testing a potential booster shot and are testing the two double shot in new patient groups including pregnant women twelve to fifteen year olds and children from six months to eleven years old I'm a Donahue

Coming up next